Show items per page
Elements: 4
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration Lauper, Kim; Nordström, Dan C; Pavelka, Karel; Hernández, Maria Victoria; ... Gabay, Cem 2018
add to browser selection
Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Klami Kristianslund, Eirik; ... Gabay, Cem 2018
add to browser selection
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis Lauper, Kim; Mongin, Denis; Iannone, Florenzo; Kristianslund, Eirik K; ... Gabay, Cem 2019
add to browser selection
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution Lauper, Kim; Mongin, Denis; Alpizar Rodriguez, Deshire; Codreanu, Catalin; ... Courvoisier, Delphine 2019